$0.58
Hepion Pharmaceuticals is a biotechnology business based in the US. Hepion Pharmaceuticals shares (HEPA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.82 – an increase of 40.62% over the previous week. Hepion Pharmaceuticals employs 22 staff and has a market cap (total outstanding shares value) of 0.00.
What's in this guide?
Our top picks for where to buy Hepion Pharmaceuticals stock
- Earn 4.5% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Unlimited bonus amounts Oct 16-27
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Hepion Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – HEPA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Hepion Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Hepion Pharmaceuticals stock price (NASDAQ: HEPA)
Use our graph to track the performance of HEPA stocks over time.Hepion Pharmaceuticals shares at a glance
Latest market close | $0.82 |
---|---|
52-week range | $0.55 - $5.30 |
50-day moving average | $0.69 |
200-day moving average | $1.48 |
Wall St. target price | $30.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-6.41 |
Is it a good time to buy Hepion Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Hepion Pharmaceuticals price performance over time
Historical closes compared with the close of $0.818 from 2024-10-18
1 week (2024-10-14) | 42.26% |
---|---|
1 month (2024-09-20) | 17.02% |
3 months (2024-07-19) | -19.80% |
6 months (2024-04-19) | -59.30% |
1 year (2023-10-20) | -81.41% |
---|---|
2 years (2022-10-21) | 65.92% |
3 years (2021-10-21) | 1.57 |
5 years (2019-10-21) | 3.41 |
Hepion Pharmaceuticals financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -92.82% |
Return on equity TTM | -189.52% |
Profit margin | 0% |
Book value | $0.32 |
Market Capitalization | $3.4 million |
TTM: trailing 12 months
Hepion Pharmaceuticals share dividends
We're not expecting Hepion Pharmaceuticals to pay a dividend over the next 12 months.
Have Hepion Pharmaceuticals's shares ever split?
Hepion Pharmaceuticals's shares were split on a 1:20 basis on 10 May 2023 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Hepion Pharmaceuticals shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Hepion Pharmaceuticals shares which in turn could have impacted Hepion Pharmaceuticals's share price.
Hepion Pharmaceuticals share price volatility
Over the last 12 months, Hepion Pharmaceuticals's shares have ranged in value from as little as $0.5525 up to $5.2999. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hepion Pharmaceuticals's is 1.836. This would suggest that Hepion Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Hepion Pharmaceuticals overview
Hepion Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It develops Rencofilstat, a cyclophilin inhibitor is in Phase 2b clinical trial to target multiple pathologic pathways involved in the progression of liver disease and treat non-alcoholic steatohepatitis (NASH), as well as preclinical studies of Rencofilstat shows reduction in liver fibrosis, liver inflammation, liver tumor burden, and titers of HBV, HCV, HDV, and HIV-1, and has demonstrated antiviral activities for hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc.
Frequently asked questions
nullWhat percentage of Hepion Pharmaceuticals is owned by insiders or institutions?
Currently 0.102% of Hepion Pharmaceuticals shares are held by insiders and 14.526% by institutions. How many people work for Hepion Pharmaceuticals?
Latest data suggests 22 work at Hepion Pharmaceuticals. When does the fiscal year end for Hepion Pharmaceuticals?
Hepion Pharmaceuticals's fiscal year ends in December. Where is Hepion Pharmaceuticals based?
Hepion Pharmaceuticals's address is: 399 Thornall Street, Edison, NJ, United States, 08837 What is Hepion Pharmaceuticals's ISIN number?
Hepion Pharmaceuticals's international securities identification number is: US4268971045 What is Hepion Pharmaceuticals's CUSIP number?
Hepion Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 21234W400
More guides on Finder
-
ZippyLoan Review: Fast Loans Under $15k for Poor Credit Borrowers
Marketplace for loans up to $15,000 with quick approvals and options for all credit types.
-
RISE Credit Review: Borrow & Build Credit, But At High Interest Rates
Review of RISE Credit, a lender that offers fast funding but high APRs.
-
iMerge Financial Review: Legit Loan Connection Service
iMerge Financial review, a connection service promising fast funding and low rates.
-
Integra Credit Review: Avoid the High Interest Rates
Review of Integra Credit installment loans, including APRs and requirements to qualify.
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
Acorn Finance Personal Loans Review
Get multiple loan offers fast using Acorn Finance with no impact on your credit score.
-
Loans for Gig Workers: Get the Cash You Need Between Jobs
It can be more challenging to find loans for gig workers, but you have plenty of options.
-
Inheritance Funding Company review
Get up to 40% of your inheritance — without paying any interest.
-
6 stocks like Nvidia you need to consider
Advanced Micro Devices (AMD), Intel Corporation (INTC) and Qualcomm Inc (QCOM) are top stocks like Nvidia. See our full list here.
Ask a question